MoneyWorks4Me

The March 2024 quarter revenue stood at Rs. 924.03 millions, up 11.92% as compared to Rs. 825.60 millions during the corresponding quarter last year.A radical decline of -82.07% was reported in the net profit of the company for the quarter ended March 2024 to Rs. 31.38  millions from Rs. 174.97 millions.The company reported a good operating profit of 324.54 millions compared to 260.92 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 924.03 825.60 11.92 3654.69 3115.29 17.31 3654.69 3115.29 17.31
Other Income 32.10 28.10 14.23 588.09 98.08 499.60 588.09 98.08 499.60
PBIDT 324.54 260.92 24.38 1639.95 846.96 93.63 1639.95 846.96 93.63
Interest 0.48 0.57 -15.79 1.57 1.35 16.30 1.57 1.35 16.30
PBDT 134.58 260.35 -48.31 1448.90 845.61 71.34 1448.90 845.61 71.34
Depreciation 30.67 27.57 11.24 108.98 102.83 5.98 108.98 102.83 5.98
PBT 103.91 232.78 -55.36 1339.92 742.78 80.39 1339.92 742.78 80.39
TAX 72.53 57.81 25.46 258.69 187.51 37.96 258.69 187.51 37.96
Deferred Tax -2.83 5.52 -151.27 -10.82 4.97 -317.71 -10.82 4.97 -317.71
PAT 31.38 174.97 -82.07 1081.23 555.27 94.72 1081.23 555.27 94.72
Equity 223.65 223.65 0.00 223.65 223.65 0.00 223.65 223.65 0.00
PBIDTM(%) 35.12 31.60 11.13 44.87 27.19 65.05 44.87 27.19 65.05
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..